Search

everythinglearnresearchcommunity

for

Search:↓

ALRV5XR significantly improves hair density in women with hair loss and is well-tolerated.

Neoadjuvant chemotherapy followed by surgery leads to fewer severe complications and better quality of life than immediate surgery in advanced ovarian cancer patients with high tumor load.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

Breast pain is common and usually not linked to cancer, with treatment varying by severity.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Spironolactone may be a better acne treatment for adult women than antibiotics.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

Gemcitabine and paclitaxel are effective and safe as first-line treatment for metastatic breast cancer.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

A postmenopausal woman had high testosterone from her right adrenal gland, leading to recommended surgery.

A postmenopausal woman's masculine symptoms improved after surgery for a hormone-producing ovarian tumor.

Future osteoporosis treatments should focus on increasing bone growth, with many promising options available.

The lotion CG428 did not show effectiveness in treating permanent hair loss in breast cancer survivors.

Hormone-replacement therapy improved a woman's skin condition known as lymphomatoid papulosis.

Long-term estrogen therapy in postmenopausal women can improve certain health markers, hair loss is common regardless of hormone use, stopping estrogen doesn't increase breast cancer risk, smoking does, and a balanced BMI is linked to lower mortality.

Some antiandrogens may lower testosterone better than others, but it's unclear which is best for feminization in transgender women; more research is needed.

Ayurveda-based care may improve quality of life for breast cancer patients without serious side effects.

Dutasteride is effective and safe for treating common hair loss, and it's more potent than finasteride, leading to better hair growth and thickness.

Nemolizumab improved both severe atopic dermatitis and alopecia areata in one patient.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

Doxazosin may cause breast enlargement and pain in men.

Five-alpha reductase inhibitors, like finasteride and dutasteride, can treat enlarged prostates, improve urination, reduce need for prostate surgery, and lower the risk of prostate cancer, but may increase the risk of higher grade prostate cancer. They can also treat male pattern baldness.

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

Abrocitinib effectively treats severe alopecia areata with significant improvement and no side effects.

Certain Dibenzo derivatives may help treat prostate cancer.

Medications for hair loss and prostate issues can significantly increase the risk of sexual side effects and other negative symptoms.

Giving docetaxel weekly at 40 mg/m² is manageable and has low toxicity for cancer patients.

Finasteride may improve prostate cancer treatment outcomes.

Cyproterone acetate effectively treats virilized women, especially under 35, despite some side effects.

Scientists at the University of Michigan Medical School successfully created a special compound that can be used to improve imaging of prostate cancer.